Our Educational Projects – 2022/2023
The following projects are currently ongoing and will be developed by SPCC on a long-term basis.
The following projects are currently ongoing and will be developed by SPCC on a long-term basis.
Supported by Bristol Myers Squibb, Cloud Pathology Group and Veracyte
Starting from the major outcomes of the “Improving Efficiency in Cancer Care: 2020-2021” project, SPCC is organising with All.Can an educational project for 2023 focusing on the essential role of Data in Cancer Care to improve outcomes across the Cancer Care Continuum (from screening to diagnosis, from treatment and care to follow-up and survivorship).
Supported by a grant from Eli Lilly & Company
Sharing Progress in Cancer Care and Lilly are collaborating and seeking grant proposals in support of improving care of Early Breast Cancer (EBC) patients in Europe.
Supported by AstraZeneca, Novartis and Roche
Artificial intelligence has given rise to great expectations for improving cancer diagnosis, prognosis and therapy but has also highlighted some of its inherent outstanding challenges, such as potential implicit biases in training datasets, data heterogeneity and the scarcity of external validation cohorts.
SPCC will carry out a project to develop knowledge and competences on integration of AI in Cancer Care Continuum: from diagnosis to clinical decision-making.